- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
How a Patient Finally Resolved a Clostridioides difficile Infection
After struggling for months with a Clostridioides difficile infection, Freda Pyles traveled from her home to rural Pennsylvania to Yale-New Haven Hospital in Connecticut for the therapy that ultimately healed her.
Freda Pyles, a resident of rural Pennsylvania, spent months with a recurrent Clostridioides difficile infection in 2021 into 2022; in this interview, she describes the therapy she received at Yale-New Haven Hospital that ultimately healed her.
Transcript
Is the treatment that ultimately worked for your Clostridioides difficile a fecal transplant?
Yes, it was the only thing that worked. And I felt good the very next day. The very next day, I got up and I said to my friends that we were staying with, I said, I feel good. I feel really good. I think I can go out and do something. And our friends that are both doctors said, are you sure? I said, yes, I feel good enough to go out and do something today. So my friend and I went and got a manicure. And I didn't have any problems that whole day. We got the manicure, we went to Trader Joe's, we went to Costco, we joined our husbands for dinner. And I felt good. And the next day we were leaving, and I felt good enough to get my car and drive. I just—it was, it was such a wonderful feeling. I said, I felt good like I have never felt good before.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More
